Sniping Cancer Stem Cells with Nanomaterials
Authors:
- 27 November 2023
- journal article
- review article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (23) , 23262-23298
Abstract
Cancer stem cells (CSCs) drive tumor initiation, progression, and therapeutic resistance due to their self-renewal and differentiation capabilities. Despite encouraging progress in cancer treatment, conventional approaches often fail to eliminate CSCs, necessitating the development of precise targeted strategies. Recent advances in materials science and nanotechnology have enabled promising CSC-targeted approaches, harnessing the power of tailoring nanomaterials in diverse therapeutic applications. This review provides an update on the current landscape of nanobased precision targeting approaches against CSCs. We elucidate the nuanced application of organic, inorganic, and bioinspired nanomaterials across a spectrum of therapeutic paradigms, encompassing targeted therapy, immunotherapy, and multimodal synergistic therapies. By examining the accomplishments and challenges in this potential field, we aim to inform future efforts to advance nanomaterial-based therapies toward more effective "sniping" of CSCs and tumor clearance.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFC2504200)
- Wuhan University (XNJC202303)
- Fundamental Research Funds for the Central Universities (2042022dx0003)
- National Natural Science Foundation of China (82273202, 82072996)
This publication has 417 references indexed in Scilit:
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletionNature Medicine, 2013
- Metabolic Plasticity in Stem Cell Homeostasis and DifferentiationCell Stem Cell, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patientsCell Research, 2011
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasionOncogene, 2011
- NANOG regulates glioma stem cells and is essential in vivo acting in a cross‐functional network with GLI1 and p53The EMBO Journal, 2010
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- Identification of cells initiating human melanomasNature, 2008
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006